Accelerating response to antidepressant treatment in depression: a review and clinical suggestions
S Nakajima, T Suzuki, K Watanabe, H Kashima… - Progress in Neuro …, 2010 - Elsevier
OBJECTIVE: The primary objective of this article is to review the literature regarding the
speed of response to antidepressant drugs and potential strategies to accelerate the …
speed of response to antidepressant drugs and potential strategies to accelerate the …
Strategies to enhance the therapeutic efficacy of antidepressants: targeting residual symptoms
BT Kurian, TL Greer, MH Trivedi - Expert review of …, 2009 - Taylor & Francis
Major depressive disorder (MDD) is an illness of great morbidity that affects many people
across the world. The current goal for treatment of MDD is to achieve remission (ie, no …
across the world. The current goal for treatment of MDD is to achieve remission (ie, no …
A pilot study of the efficacy and safety of paroxetine augmented with risperidone, valproate, buspirone, trazodone, or thyroid hormone in adult Chinese patients with …
Y Fang, C Yuan, Y Xu, J Chen, Z Wu… - Journal of clinical …, 2011 - journals.lww.com
To compare the efficacy and safety of augmenting paroxetine with risperidone, buspirone,
valproate, trazodone, or thyroid hormone in patients with treatment-resistant depression …
valproate, trazodone, or thyroid hormone in patients with treatment-resistant depression …
Recovery from major depression in older adults receiving augmentation of antidepressant pharmacotherapy
MA Dew, EM Whyte, EJ Lenze… - American Journal of …, 2007 - Am Psychiatric Assoc
Objective: Few data are available concerning the utility of augmentation in late-life
depression treatment. The authors examined likelihood, speed, and predictors of recovery in …
depression treatment. The authors examined likelihood, speed, and predictors of recovery in …
[HTML][HTML] L-methylfolate plus SSRI or SNRI from treatment initiation compared to SSRI or SNRI monotherapy in a major depressive episode
LD Ginsberg, AY Oubre, YA DaouD - Innovations in clinical …, 2011 - ncbi.nlm.nih.gov
Objective: Evaluate the efficacy of L-methylfolate in combination with SSRI or SNRI
compared to SSRI or SNRI monotherapy in a major depressive episode. Design: A …
compared to SSRI or SNRI monotherapy in a major depressive episode. Design: A …
An exploratory study of combination buspirone and melatonin SR in major depressive disorder (MDD): a possible role for neurogenesis in drug discovery
We used in vitro neurogenesis-based human neural stem cell (hNSCs) assays and rodent in
vivo behavioral assays to identify potential novel antidepressants. A combination of …
vivo behavioral assays to identify potential novel antidepressants. A combination of …
Efficacy and tolerability of adjunctive ziprasidone in treatment-resistant depression: a randomized, open-label, pilot study.
DL Dunner, JD Amsterdam, RC Shelton… - Journal of Clinical …, 2007 - psychiatrist.com
Objective: To evaluate the efficacy and tolerability of adjunctive ziprasidone in subjects with
treatment-resistant major depressive disorder (DSM-IV criteria) without psychotic features …
treatment-resistant major depressive disorder (DSM-IV criteria) without psychotic features …
Serotonin effects on human iPSC-derived neural cell functions: from mitochondria to depression
I Cardon, S Grobecker, F Jenne, T Jahner… - Molecular …, 2024 - nature.com
Depression's link to serotonin dysregulation is well-known. The monoamine theory posits
that depression results from impaired serotonin activity, leading to the development of …
that depression results from impaired serotonin activity, leading to the development of …
Switching to duloxetine in selective serotonin reuptake inhibitor non-and partial-responders: effects on painful physical symptoms of depression
DGS Perahia, D Quail, D Desaiah, AL Montejo… - Journal of psychiatric …, 2009 - Elsevier
Painful physical symptoms (PPS) are common in patients with depression. Our objective
was to evaluate the presence of PPS in a sample of SSRI non-or partial-responders with …
was to evaluate the presence of PPS in a sample of SSRI non-or partial-responders with …
An integrated analysis of olanzapine/fluoxetine combination in clinical trials of treatment-resistant depression.
MH Trivedi, ME Thase, O Osuntokun… - Journal of Clinical …, 2009 - psychiatrist.com
Objective: To evaluate the efficacy of olanzapine/fluoxetine combination (OFC) versus
olanzapine or fluoxetine monotherapy across all clinical trials of treatment-resistant …
olanzapine or fluoxetine monotherapy across all clinical trials of treatment-resistant …